MDXH
insider transactionsMDxHealth SA — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Officer
$0
154.1K sh
Own New
-
Grant·A
Officer
$0
83.0K sh
Own New
-
Grant·A
VP, Finance and Accounting
$0
65.0K sh
Own New
-
Grant·A
VP, Finance and Accounting
$0
35.0K sh
Own New
-
Grant·A
Chief Executive Officer
$0
612.4K sh
Own New
-
Grant·A
Chief Executive Officer
$0
329.8K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
217.0K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
116.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Joseph Sollee | Grant A | 154.1K | $0 |
| Jun 1, 2026 | Joseph Sollee | Grant A | 83.0K | $0 |
| Jun 1, 2026 | Brendan Oconnell | Grant A | 65.0K | $0 |
| Jun 1, 2026 | Brendan Oconnell | Grant A | 35.0K | $0 |
| Jun 1, 2026 | Michael Mcgarrity KEY | Grant A | 612.4K | $0 |
| Jun 1, 2026 | Michael Mcgarrity KEY | Grant A | 329.8K | $0 |
| Jun 1, 2026 | Hilde Windels | Grant A | 10.0K | $0 |
| Jun 1, 2026 | Sanford Jay Siegel | Grant A | 10.0K | $0 |
| Jun 1, 2026 | Michael Holder | Grant A | 10.0K | $0 |
| Jun 1, 2026 | Koen Hoffman | Grant A | 10.0K | $0 |
| Jun 1, 2026 | Don M Hardison | Grant A | 10.0K | $0 |
| Jun 1, 2026 | John Bellano | Grant A | 217.0K | $0 |
| Jun 1, 2026 | John Bellano | Grant A | 116.0K | $0 |
About MDXH insider trading
This page tracks insider transactions for MDxHealth SA (MDXH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.